ArticleFrontiers in medicine2026
Effectiveness of a multicomponent PDCA-based infusion safety management strategy in patients with pulmonary tuberculosis: a non-randomized historical-control study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the association between a multicomponent PDCA-based infusion safety management strategy and intraoperative peripheral intravenous (PIV) outcomes in adults with pulmonary tuberculosis. Methods: This non-randomized historical-control study included 92 adults undergoing thoracic surgery: 46 historical controls receiving routine infusion management and 46 patients receiving a multicomponent intervention integrating PDCA-based quality improvement, staff training, standardized protocols, interdepartmental collaboration, audit and feedback, and two auxiliary devices. Baseline demographic and surgical characteristics were comparable between groups. Results: Compared with historical controls, the intervention group had lower rates of erythema/tenderness [8.7% vs. 69.6%; RR, 0.13 (95% CI, 0.05-0.33)], catheter dislodgement [2.2% vs. 28.3%; RR, 0.08 (95% CI, 0.01-0.56)], and catheter occlusion [4.3% vs. 43.5%; RR, 0.10 (95% CI, 0.02-0.40); all Conclusion: The multicomponent PDCA-based strategy was associated with fewer PIV-related safety events, longer catheter dwell time, and higher satisfaction. However, because the intervention combined process changes with two devices and used a historical control, the observed differences cannot be attributed independently to PDCA or either device.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.